We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Hogan Lovells advises PerkinElmer, Inc. on the acquisition of EUROIMMUN Medizinische Labordiagnostika AG

19 June 2017

Press Contact

Peter Herkenhoff

Corporate Communications Manager Germany
Dusseldorf
+49 211 13 68 469

Led by Munich Partner and head of the German Corporate Practice Lutz Angerer Hogan Lovells has advised listed US company PerkinElmer, Inc. on the acquisition of EUROIMMUN Medizinische Labordiagnostika AG for a consideration of EUR 1.2 billion by way of a share deal.

The acquisition grows PerkinElmer's Diagnostics business into a USD 1 billion franchise. It allows PerkinElmer to enter the autoimmune and allergy diagnostic markets, while offering new infectious disease capabilities to customers in China. In addition, as a market leader in the US for reproductive health, PerkinElmer will now be able to cross-sell its newly acquired autoimmune, allergy and infectious disease screening solutions within an established channel. 

Lutz Angerer has advised PerkinElmer since 2004 on various M&A transactions, among others on the acquisition of chemagen Biopolymer-Technologie AG, Evotec Technologies GmbH and Elcos AG as well as on the disposal of its Medical Imaging Business on 1 May 2017.  

"As a global full-service law firm with a very strong life sciences industry expertise we are the perfect law firm for transactions like this", said Lutz Angerer. 

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. With around 9,000 employees worldwide PerkinElmer helps to solve critical issues especially impacting the diagnostics, discovery and analytical solutions markets. Its innovative detection, imaging, informatics and service capabilities help customers gain more accurate insights in an early stage and improve lives and the world around us. PerkinElmer reported revenues of approximately USD 2.1 billion in 2016, serves customers in more than 150 countries, and is a component of the S&P 500 Index. 

Founded in 1987 and based in Lübeck, Germany, EUROIMMUN is a leading global provider of test systems and automation solutions for diagnosis of autoimmune and infectious diseases and allergies. EUROIMMUN's customers include clinical and commercial medical laboratories, regional and state hospital laboratories, clinicians and researchers. 

Hogan Lovells for PerkinElmer:

Dr. Lutz Angerer (Partner, Lead), Andreas Thun (Counsel), Thomas Weber (Counsel), Dr. Thomas Richter (Associate), Dr. Benjamin Fekonja (Associate, Corporate/M&A, Munich); 

Stefanie Kern (Partner), Sabrina Handke (Senior Associate, Real Estate, Munich);

Dr. Falk Loose (Counsel, Tax, Munich).

Contacts

 
Loading data